Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Data for: A pragmatic trial of glucocorticoids for community acquired pneumonia

Domaine:

healthcare

Type de record:

dataset
Créateur:
Lucinde, Ruth KhadembuGathuri, HenryEtyang, Anthony
Éditeur:
LucEtyThe
Éditeur:
Har
Hôte:avatar

This dataset was generated from a pragmatic, randomized controlled trial evaluating the effectiveness and safety of adjunctive low-dose glucocorticoids in adults hospitalized with community-acquired pneumonia (CAP) in Kenya. The study was conducted across 18 public hospitals between April 2022 and June 2024 to determine whether oral glucocorticoids, when added to standard care, reduce 30-day mortality compared with standard care alone in low-resource settings. A total of 2,180 participants were enrolled and randomized to receive either standard care (n = 1,091) or standard care plus glucocorticoids (n = 1,089). Data include baseline clinical and demographic characteristics, type and duration of glucocorticoid therapy, comorbidities, antibiotic use, vital status at multiple time points (14, 21, and 30 days), and records of adverse and serious adverse events for the 2180 participants. Follow-up completeness at day 30 was 95.5%.

Visit

doi.orgdataverse.harvard.edu

Tags

Medicine, Health and Life SciencesCorticosteroidscommunity acquired pneumoniaadultsmortality

Licenses

info:eu-repo/semantics/restrictedAccessCreative Commons Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/legalcode

Similaires

ToolCAP: Novel Tools to Improve the Management of Paediatric Community-Acquired Pneumonia – a Preliminary Study Protocol for a Randomised Controlled TrialRisk factors for community-acquired pneumonia among adults in Kenya: a case-control study.Distinct Patterns of Clinical Features and Cardiac Biomarker Elevation in Community-Acquired Pneumonia and COVID-19 PneumoniaReplication data and code for "Community delivery of antiretroviral drugs: A non-inferiority cluster-randomized pragmatic trial in Dar es Salaam, Tanzania"Validation of risk prediction for outcomes of severe community-acquired pneumonia among under-five children in Amhara region, Northwest EthiopiaReplication Data for: "Community health workers to improve uptake of maternal healthcare services: A cluster-randomized pragmatic trial in Dar es Salaam, Tanzania"

ToolCAP: Novel Tools to Improve the Management of Paediatric Community-Acquired Pneumonia – a Preliminary Study Protocol for a Randomised Controlled Trial

Background Lower respiratory tract infections (LRTIs), particularly pneumonia, are a leading cause o

Risk factors for community-acquired pneumonia among adults in Kenya: a case-control study.

Background

Pneumonia is a leading cause of morbidity and mortality among adults worldwi

Distinct Patterns of Clinical Features and Cardiac Biomarker Elevation in Community-Acquired Pneumonia and COVID-19 Pneumonia

No previous sub-Saharan studies have compared patients with community-acquired pneumonia (CAP) and C

Replication data and code for "Community delivery of antiretroviral drugs: A non-inferiority cluster-randomized pragmatic trial in Dar es Salaam, Tanzania"

This is the data and code for the upcoming publication in PLOS Medicine entitled "Community delivery

Validation of risk prediction for outcomes of severe community-acquired pneumonia among under-five children in Amhara region, Northwest Ethiopia

Background Globally there are over 1,400 cases of pneumonia per 100,000 children every year, where

Replication Data for: "Community health workers to improve uptake of maternal healthcare services: A cluster-randomized pragmatic trial in Dar es Salaam, Tanzania"

This page provides the full dataset, cleaning code, and analysis code for the household survey and p